(NYSE: WAT) Waters's forecast annual revenue growth rate of 5.53% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.12%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.59%.
Waters's revenue in 2025 is $2,983,253,000.On average, 5 Wall Street analysts forecast WAT's revenue for 2025 to be $184,929,671,358, with the lowest WAT revenue forecast at $183,471,698,678, and the highest WAT revenue forecast at $186,245,595,843. On average, 6 Wall Street analysts forecast WAT's revenue for 2026 to be $197,226,808,036, with the lowest WAT revenue forecast at $192,809,448,360, and the highest WAT revenue forecast at $201,356,738,813.
In 2027, WAT is forecast to generate $211,495,480,833 in revenue, with the lowest revenue forecast at $205,061,536,658 and the highest revenue forecast at $217,929,425,009.